NCT06311032View on ClinicalTrials.gov

Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas

CompletedOBSERVATIONAL

Enrollment

72

Participants

Timeline

Start Date

March 29, 2023

Primary Completion Date

June 28, 2023

Study Completion Date

July 28, 2023

Conditions

Surgery Risk Assessment

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER